Dugar, Ashish
Sarepta Therapeutics (United States)
3 papers on CoChat
Most cited papers
- Verified
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial
Mendell, J. R., Sahenk, Z., Lehman, K., Nease, C., Lowes, L. P., Miller, N. F., Iammarino, M. A., Alfano, L. N., Nicholl, A., Al-Zaidy, S., et al. (2020) · JAMA Neurology
Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research
Cited by 405
- Verified
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?
Keefe, R. S. E., Buchanan, R. W., Marder, S. R., Schooler, N. R., Dugar, A., Zivkov, M., & Stewart, M. (2013) · Schizophrenia Bulletin
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 138
- Verified
Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration
Oliver-Fernandez, A., Bakal, J., Segal, S., Shah, G. K., Dugar, A., & Sharma, S. (2005) · Canadian Journal of Ophthalmology
Retinal Diseases and TreatmentsRetinal Imaging and Analysis
Cited by 50
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free